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Abstract
Fibromuscular dysplasia (FMD), formerly called fibromuscular fibroplasia, is a group of nonatherosclerotic,
noninflammatory arterial diseases that most commonly involve the renal and carotid arteries. The
prevalence of symptomatic renal artery FMD is about 4/1000 and the prevalence of cervicocranial FMD is
probably half that. Histological classification discriminates three main subtypes, intimal, medial and
perimedial, which may be associated in a single patient. Angiographic classification includes the multifocal
type, with multiple stenoses and the 'string-of-beads' appearance that is related to medial FMD, and tubular
and focal types, which are not clearly related to specific histological lesions. Renovascular hypertension is
the most common manifestation of renal artery FMD. Multifocal stenoses with the 'string-of-beads'
appearance are observed at angiography in more than 80% of cases, mostly in women aged between 30
and 50 years; they generally involve the middle and distal two-thirds of the main renal artery and in some
case also renal artery branches. Cervicocranial FMD can be complicated by dissection with headache,
Horner's syndrome or stroke, or can be associated with intracerebral aneurysms with a risk of
subarachnoid or intracerebral hemorrhage. The etiology of FMD is unknown, although various hormonal
and mechanical factors have been suggested. Subclinical lesions are found at arterial sites distant from the
stenotic arteries, and this suggests that FMD is a systemic arterial disease. It appears to be familial in 10%
of cases. Noninvasive diagnostic tests include, in increasing order of accuracy, ultrasonography, magnetic
resonance angiography and computed tomography angiography. The gold standard for diagnosing FMD is
catheter angiography, but this invasive procedure is only used for patients in whom it is clinically pertinent
to proceed with revascularization during the same procedure. Differential diagnosis include
atherosclerotic stenoses and stenoses associated with vascular Ehlers-Danlos and Williams' syndromes,
and type 1 neurofibromatosis. Management of cases with renovascular hypertension includes
antihypertensive therapy, percutaneous angioplasty of severe stenoses, and reconstructive surgery in cases
with complex FMD that extends to segmental arteries. The therapeutic options for securing ruptured
intracerebral aneurysms are microvascular neurosurgical clipping and endovascular coiling. Stenosis
progression in renal artery FMD is slow and rarely leads to ischemic renal failure.
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Definition and diagnostic criteria
Disease name/synonyms
Early descriptions of the disease used the terms fibromus-
cular hyperplasia or fibroplasia, but now the term fibro-
muscular dysplasia (FMD) is used. McCormack et al in
1958 reported a pathological description of fibromuscu-
lar hyperplasia in four patients with renovascular hyper-
tension [1]. In 1965, Hunt et al [2] observed that the
disease was heterogeneous and not necessarily associated
with hyperplasia, and introduced the term FMD. It was
soon recognized that FMD could be present in carotid
arteries without documented renal artery FMD or hyper-
tension [3]. FMD is currently defined as an idiopathic, seg-
mental, non-inflammatory and non-atherosclerotic
disease of the musculature of arterial walls, leading to ste-
nosis of small and medium-sized arteries. FMD may be
familial (OMIM #135580).
Pathologic classification
A pathological classification of renal artery FMD was pro-
posed by McCormack et al [4,5] and revised by Stanley [6].
It was based on the dominant arterial wall layer involved:
the intima, media or adventitia. Three main types of FMD
have been identified: intimal, medial and perimedial [6],
and these types have also been described in extrarenal
arteries [7]. Intimal FMD, which accounts for 5% or renal
artery FMD cases, is characterized by irregularly arranged
mesenchymal cells within a loose matrix of subendothe-
lial connective tissue and a fragmented internal elastic
lamina. Nearly 85% of all FMD stenoses in the renal arter-
ies are medial FMD; the lesion is a homogeneous collar of
elastic tissue that presents as multiple stenoses inter-
spersed with aneurismal outpouchings, with a preserved
internal elastic lamina. Perimedial FMD affects approxi-
mately 10% of dysplastic renal arteries and involves exces-
sive tissue deposition at the junction of the media and
adventitia. The three types are not mutually exclusive.
Indeed, Stanley reported that medial and perimedial FMD
lesions can coexist in the same arterial segment [6]; and
Alimi et al analyzed arterial segments from 33 patients
and found that more than one artery layer was involved in
25 (66%) of the 38 specimens studied [8].
Since reports of successful outcomes of angioplasty in
patients with renal artery FMD [9], surgery has been used
only rarely for patients with FMD and consequently histo-
logical verification is available for only a small minority of
cases. As a result, contemporary reports infer the patho-
logical type of FMD from the angiographic appearance of
arterial lesions. Table 1 shows the distribution of patho-
logical types and the angiographic appearance of FMD in
two series in which both pathological and angiographic
findings were reported [3,4].
Pathological-angiographic correlations
Kincaid  et al described angiographic features in 125
patients with FMD, including 60 patients who underwent
surgery and provided arterial tissue for histological exam-
ination [3]. They proposed an angiographic classification
of FMD into four types. The multifocal type, with multiple
stenoses and the 'string-of-beads' appearance, was present
in 78 cases (62%); the tubular type, with a long concentric
stenosis was present in 17 cases (14%); the focal type,
with solitary stenosis less than 1 cm in length, was present
in 9 cases (7%); and 21 patients (17%) had mixed-type
stenoses. Among the 60 stenoses for which both radiolog-
ical and histological assessments were available (Table 1),
all 38 multifocal stenoses were associated with medial
FMD, whereas focal and tubular stenoses were not specif-
ically associated with histological type. Similar results
were obtained in a pathological-angiographic correlation
study at the Cleveland Clinic [4]. The "string-of-beads"
sign (Figure 1) is the most suggestive and most frequent
aspect of FMD [10], whereas focal and tubular stenoses
only differ by the length of the stenosis with an arbitrary
cut-off (Figure 2). A conservative conclusion is that multi-
focal stenoses with the "string-of-beads" feature is charac-
teristic of FMD [3,4,10] and probably denotes the
presence of the medial type FMD [3], whereas other angi-
Table 1: Pathological-angiographic correlations. Most common lesions in patients who underwent both angiographic and pathological 
renal artery examinations
Total FMD type Angiographic appearance
Pathologic classification Number Distribution String of beads" Focal Tubular
Mayo Clinic [3] 60
Intimal 5 0 2 3
Medial 53 38 3 12
Periarterial 2 0 0 2
Cleveland Clinic [4] 67
Intimal 14 0 14 0
Medial 53 46 7 0
Periarterial 0Orphanet Journal of Rare Diseases 2007, 2:28 http://www.OJRD.com/content/2/1/28
Page 3 of 8
(page number not for citation purposes)
ographic aspects cannot be related to specific histological
lesions.
Arterial bed distribution
Most commonly affected are the renal and carotid arteries.
Involvement of the axillary, iliac, basilar, hepatic and
intracranial arteries has also been reported. In a compre-
hensive review of the literature, Mettinger and Ericson
analyzed reports concerning a total of 1197 patients with
FMD [11]. Renal arteries were involved in 58% of cases,
cervicocranial arteries in 32%, and other arteries in 10%.
The type of FMD and any coexistence of FMD in several
arterial beds were not reported. In a series of 104 patients
with renal artery FMD documented at angiography [12],
81 (78%) had the string-of-bead sign; FMD affected both
renal arteries in 54 patients. Among the 81 patients in
whom the carotid arteries were examined, 9 (11%) had
carotid artery FMD. In a series of 37 patients with carotid
artery FMD [13], 23 (62%) had the "string-of-beads" fea-
ture; half the patients were hypertensive, but none under-
went renal artery angiography.
Unlike atherosclerotic stenoses, stenoses due to FMD
rarely affect the ostial or proximal segments of arteries.
FMD stenoses of renal arteries are usually truncal or distal
and may involve arterial branches [3-7]; they are more fre-
quent on the right side [3,7]. Most of carotid artery FMD
lesions occur adjacent to the C1–2 interspace [13,14].
FMD-related aneurysms and dissection
Macroaneurysms affecting the renal or carotid arteries are
more frequent in FMD than in the general population (see
Epidemiology section below). As intracranial aneurysms
may rupture and lead to subarachnoid or intracerebral
hemorrhage, the American Heart Association recom-
mends performing magnetic resonance angiography of
the head in patients with cervical artery FMD [15]. Spon-
taneous cervical artery dissections are a common cause of
stroke in young and middle-aged adults and are associ-
ated with FMD in about 15% of cases [16]. Spontaneous
renal artery dissections are rare but frequently coexist with
FMD [17,18]. Aneurysms and dissections are considered
to be complications of FMD but frequently arise in indi-
viduals with no FMD. Therefore, their presence without
direct evidence of FMD does not suffice to diagnose the
condition [6].
Epidemiology
Prevalence
The prevalence of FMD is not precisely known. Ten to
20% of documented renal artery stenoses are the conse-
quence of FMD, and renovascular hypertension is docu-
mented in less than 1 to 2% of hypertensive patients.
Assuming a 20% prevalence of hypertension in middle-
aged subjects, the prevalence of clinically significant renal
artery FMD can be estimated to be about 0.4%. The prev-
alence of asymptomatic renal artery FMD is, however, one
order of magnitude higher: four reports of angiographic
findings for a total of 3181 potential kidney donors
describe 139 subjects (4.4%) with evidence of FMD [19-
22]. The reports did not provide details concerning the
radiological criteria used to define the condition, how-
ever. The number of reported cases of carotid artery FMD
is about half that of renal artery FMD (see above) [11].
Renal artery aneurysms were identified in four of 716
(0.6%) potential kidney donors in one series, all four hav-
ing lesions suggestive of FMD [21]; similarly 12 of the 125
(9.6%) patients with renal artery FMD reported by Kin-
caid et al had renal artery aneurysms [3]. The prevalence
of intracranial aneurysms in the general population is esti-
mated to be 1 to 5% [23] but was 7.3% in a meta-analysis
combining data from 18 reports describing patients with
The "string-of-beads" feature in medial fibromuscular dyspla- sia Figure 1
The "string-of-beads" feature in medial fibromuscu-
lar dysplasia. The sign is caused by areas of relative sten-
oses alternating with small aneurysms. The diameters of the 
aneurysms exceed the normal diameter of the artery. The 
sign is characteristic of medial FMD. A similar bead appear-
ance may be seen in perimedial FMD, but the diameters of 
the beads do not exceed the normal diameter of the artery 
[10]. Note the involvement of branch renal arteries.
Unifocal (left) and tubular (right) stenoses Figure 2
Unifocal (left) and tubular (right) stenoses. Unifocal 
stenoses are typically seen in intimal FMD. Tubular stenoses 
are not specifically associated with any one of the three dom-
inant FMD types (intimal, medial or perimedial)Orphanet Journal of Rare Diseases 2007, 2:28 http://www.OJRD.com/content/2/1/28
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carotid artery FMD [24]. The prevalence of carotid artery
dissection in the general population is about 1 per
100,000. To our knowledge, there are no reliable esti-
mates of the prevalence of renal artery dissection in the
general population or of the prevalence of dissection in
patients with cervical or renal artery FMD.
Age and sex
Medial-type FMD and/or FMD showing the "string-of-
beads" appearance at angiography are usually diagnosed
in young adults and are more than four times as frequent
in women as in men. A male predominance in found in
cases with intimal-type FMD or with focal stenoses at ang-
iography, but these cases make up only a minority of
patients with FMD [12] (Figure 3).
Clinical description
Clinical presentation in renal artery FMD
The most common clinical presentation of FMD is reno-
vascular hypertension secondary to renal artery involve-
ment. Renal artery stenosis due to FMD may be associated
with all stages of hypertension, but it is most commonly
detected in patients with stage 2–3 hypertension, or
abrupt onset or resistant hypertension, since these are the
individuals who undergo the most comprehensive etio-
logical examinations. Upper abdominal quadrant or flank
bruits are common in patients with renal artery FMD
[6,12] but this clue has only limited diagnostic sensitivity
and specificity [25]. FMD may be complicated by renal
artery dissection and kidney infarction with abrupt flank
pain, hematuria and rapidly progressive hypertension
[18]. As a result of activation of the renin-angiotensin sys-
tem, hypokalemia reflecting secondary hyperaldos-
teronism may be present, particularly in cases
complicated with renal artery dissection and kidney inf-
arction [18,26]. Unlike atherosclerotic renal artery steno-
sis, FMD renal artery disease is rarely associated with high
serum creatinine levels.
Clinical presentation in carotid artery FMD
Cervical artery FMD, mainly affecting the internal carotid
artery, is seldom symptomatic. It can be discovered inci-
dentally by Doppler ultrasound during evaluation of diz-
ziness, headache, or an asymptomatic cervical bruit [11].
Neurological symptoms occur when FMD lesions are
complicated by brain ischemia, embolus, and thrombosis
in cases with dissection or associated aneurysms rupture.
Complications may present as Horner's syndrome, tran-
sient ischemic attack, ischemic stroke or subarachnoid
hemorrhage. The association in a given patient of hemor-
rhage due to aneurysm rupture and ischemic stroke due to
stenosis is characteristic of cerebral FMD [13].
FMD affecting extra-renal and extra-cervical sites
FMD affecting extra-renal and extra-cervical arteries has
been reported in celiac, superior and inferior mesenteric,
hepatic, splenic, and coronary arteries [7]. Although most
patients with digestive artery FMD are asymptomatic, they
can present with mesenteric ischemia (postprandial
abdominal pain, weight loss and epigastric bruit), or
rarely mesenteric infarction and multi-organ failure [27].
Patients with lower limb artery FMD may present with
cold legs, intermittent claudication, or evidence of distal
embolic disease. Patients with subclavian artery FMD may
present with arm weakness, paresthesias, claudication,
and subclavian steal syndrome [7,13].
Etiology/genetics
Renal artery FMD has been tentatively associated with
environmental factors and it is likely that there is a genetic
predisposition.
Environmental factors
More patients with FMD than matched controls smoke
[7,28,29] and FMD patients who smoke have a more
severe arterial disease than those who do not [30]. The
mechanisms by which smoking contributes to the etiol-
ogy of FMD have, however, not been elucidated. The well-
documented majority of women among patients with
FMD (Figure 3) suggests that exposure to endogenous or
exogenous estrogens may predispose to the condition, but
the number of pregnancies and the frequency of oral con-
traceptive use does not differ between patients with FMD
and matched controls [7,29]. Renal mobility when assum-
ing the upright position is greater in women than in men
Percentage of women by type of fibromuscular dyplasia Figure 3
Percentage of women by type of fibromuscular 
dyplasia. The blue columns indicate the percentages of 
patients who are women according to a binary pathological 
classification (adapted from [4]), and the green columns the 
percentages of patients who are women according to a 
binary angiographical classification (adapted from [12]). Note 
that women make up the majority of cases of the most prev-
alent type, medial FMD, which is associated with the "string-
of-beads" feature on angiography.Orphanet Journal of Rare Diseases 2007, 2:28 http://www.OJRD.com/content/2/1/28
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and in the right than in the left kidney [29]: FMD is more
frequent in women than in men and in the right than in
the left kidney, so it has been suggested that repeated
stretching of the renal artery may cause micro traumas
that predispose to FMD [7]. However Sang et al found that
kidney mobility during maximal respiratory cycle or dur-
ing a change in posture did not differ between patients
with FMD and matched controls with normal renal arter-
ies [29].
Genetic factors
The occurrence of renal FMD in sib pairs or identical twins
[31] suggests its possible inheritability. The first formal
pedigree analysis was performed by Rushton [32] who
suggested that FMD is transmitted as an autosomal dom-
inant disease with incomplete penetrance and variable
clinical symptoms. However, his conclusions were drawn
from interviews of relatives who were considered to have
FMD but whose arterial disease also included peripheral
arterial occlusion or coronary heart disease, i.e. conditions
more likely to be associated with atherosclerosis than with
FMD. Our retrospective analysis of 104 patients with renal
FMD showed a prevalence of 11% for familial cases, i.e.
11% of cases had at least one sibling with angiographic
evidence of renal artery FMD [12]. However, familial
detection based on angiography is not practicable in rela-
tives who are normotensive or asymptomatic. As renal
artery FMD may be associated with only mild hyperten-
sion or even present in normotensive subjects (see data
concerning kidney donors above), the presence of FMD is
probably overlooked in many relatives of index cases.
High-resolution echo-tracking methods are promising
alternatives to angiography for screening asymptomatic
relatives because subclinical alterations of the common
carotid artery wall seem common in patients with renal
artery, medial FMD [33]. Using this technique, elevated
echo-tracking scores of the carotid artery have been found
in first-degree relatives of index cases and the findings are
consistent with the possibility of autosomal dominant
transmission [34].
Few molecular genetic studies have been conducted,
because of the absence of large affected pedigrees and/or
the absence of large and well-phenotyped cohorts allow-
ing powerful case-control studies. Autoimmunity has
been implicated by a limited study showing an associa-
tion with HLA Drw6 [29] but this has not been confirmed.
In a larger series involving 161 patients and 3 sets of con-
trols, we did not find any association with functional pol-
ymorphisms of the α-1 antitrypsin gene [35]. Bofinger et
al  reported an association with polymorphisms of the
renin angiotensin system [36] but this finding also has
not been confirmed.
Diagnostic methods
Screening tests
The presence of renal artery FMD can be documented by
the following non-invasive tests (in increasing order of
accuracy): the captopril test, captopril renal scintigraphy,
Doppler ultrasound, magnetic resonance angiography,
gadolinium-enhanced magnetic resonance angiography,
and computed tomographic angiography [37]. Doppler
ultrasound is a time-consuming, examiner-dependent
procedure and has several limitations including obesity,
poor compliance for respiratory renal movement, and
failure to visualize entire arteries or to define accessory
arteries. Computed tomographic angiography is the most
specific test in patients at risk of harboring FMD renal
artery stenosis (Figure 4), but gadolinium-enhanced mag-
netic resonance angiography has the advantages of no
radiation exposure and limited nephrotoxicity. A careful
prospective multicenter comparative study found that
computed tomographic angiography and gadolinium-
enhanced magnetic resonance angiography had reasona-
bly good specificities for detecting renal artery stenosis
due to FMD (92 and 84 percent, respectively) but disap-
pointing sensitivities (64 and 62 percent, respectively)
[38].
There is no published comparative study of non-invasive
tests for detecting carotid artery FMD, although Doppler
ultrasound may disclose irregular patterns of stenosis that
are suggestive. Computed tomographic angiography and
magnetic resonance angiography are probably more effec-
tive than ultrasonography for detecting lesions of the mid-
dle and distal portions of the carotid and vertebral arteries
and may also document or rule out the association of
intracranial aneurysms.
Computed tomography angiography in a patient with medial  dibromuscular dysplasia Figure 4
Computed tomography angiography in a patient with medial 
dibromuscular dysplasia.Orphanet Journal of Rare Diseases 2007, 2:28 http://www.OJRD.com/content/2/1/28
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Confirmatory test
The commonly accepted gold standard for diagnosing
renal artery FMD is intra-arterial angiogram with digital
subtraction. This invasive test should be reserved for
patients in whom it is clinically justified to proceed with
revascularization in the same procedure. Stenosis quanti-
fication is, however, frequently difficult in medial FMD
with the "string-of-beads" appearance because multiple
web-like defects are often present in patients with FMD,
contributing to clinically significant stenoses that may not
be apparent on angiography.
Differential diagnosis
The characteristic "string-of-beads" feature is found in the
majority of patients with FMD (Table 1). In cases with
focal and tubular FMD stenoses, differential diagnoses are
atherosclerotic or inflammatory artery diseases, vascular
Ehlers-Danlos and Williams' syndromes, and type 1 neu-
rofibromatosis. FMD lesions are typically truncal or distal,
as opposed to atherosclerotic stenoses that are mostly
ostial or proximal; most patients with FMD are young and
present few or no risk factors for atherosclerosis and no
aortic plaques. In 178 consecutive angiograms from
patients with FMD or atherosclerotic renal artery stenoses,
readers blinded for age, sex, and clinical context generally
agreed on the etiology (kappa coefficient 0.677) [39].
FMD differs from inflammatory diseases like Takayasu
arteritis by the absence of inflammation or aortic stenosis.
Patients with vascular Ehlers-Danlos syndrome, with the
Williams syndrome, or with type 1 neurofibromatosis
may have stenoses of renal and visceral arteries that mimic
FMD. The diagnosis of these conditions relies on associ-
ated phenotypic traits and genetic tests: acrogeric dysmor-
phy, distal joint laxity and tiny skin elasticity in vascular
Ehlers-Danlos syndrome (confirmed by detection of
COL3A1 gene mutations) [40]; facial dysmorphy, supra-
aortic stenosis and particular behavior in Williams syn-
drome (confirmed by detection of deletion 7q1.2 using
FISH method) [41]; and specific skin lesions in neurofi-
bromatosis 1 [42].
Management
Management of renal artery FMD
The value of treatment has not been established for renal
artery FMD without hypertension. The management of
hypertension associated with renal artery FMD involves
revascularization and/or antihypertensive medication.
There have been no controlled trials comparing revascu-
larization to medication in FMD. Current recommenda-
tions reflect the knowledge acquired concerning
atherosclerotic renovascular hypertension, although indi-
cations for balloon angioplasty are wider in FMD than in
atherosclerotic renovascular disease because the blood
pressure outcome of angioplasty is more favorable in
FMD than in atherosclerosis [9]. Revascularization is rec-
ommended for patients with hemodynamically signifi-
cant renal artery stenosis – i.e. with bilateral stenoses or a
unilateral stenosis causing more than 60% reduction in
luminal diameter – and accelerated hypertension, resist-
ant hypertension, malignant hypertension, hypertension
with an unexplained unilateral small kidney, and hyper-
tension with intolerance to medication [15]. It is also use-
ful in young patients with recent-onset hypertension and
hemodynamically significant renal artery stenosis due to
FMD: in these cases the goal is to cure the hypertension.
The standard revascularization procedure is balloon angi-
oplasty with bailout stent placement if necessary. Surgical
reconstruction is indicated for patients with complex
FMD that extends to segmental arteries and those with
macroaneurysms [15]. Antihypertensive drug treatment is
indicated for patients with long-standing hypertension or
in cases with persistent hypertension following revascu-
larization. Medication includes angiotensin-converting
enzyme inhibitors, angiotensin receptor blockers, calcium
channel blockers and betablockers. In cases with hemody-
namically significant stenosis and no indication for pri-
mary revascularization, renal echography should be
performed every year and revascularization considered if
kidney length shortens by 1 cm or more.
Management of symptomatic carotid artery FMD
Management of dissecting carotid artery FMD includes
anticoagulation and, in cases with expanding or sympto-
matic pseudoanevrysm, percutaneous angioplasty or sur-
gical repair [43]. Therapeutic options for securing
ruptured intracerebral aneurysms are microvascular neu-
rosurgical clipping and endovascular coiling [44].
Natural history and prognosis
Renal artery FMD, mainly of focal or tubular types, may
progress to more severe stenosis and rarely to renal artery
occlusion [3,7,45-47]. Multivessel FMD may be rapidly
progressive, particularly in young children, sometimes in
a familial context [48,49]. Information regarding progres-
sion in FMD is limited and retrospective, however, and
the risk of progression as assessed from available studies
is probably overestimated because documentation of pro-
gression was obtained from intra-arterial angiography, a
procedure which is not routinely undertaken in patients
with favorable clinical and biological outcomes. Overall,
progression of arterial lesions is considered less severe in
FMD than in atherosclerotic renal artery stenoses [45,46].
We are not aware of any follow-up studies in patients with
untreated cervicocranial FMD.
Unresolved questions
The major aims of current research are to unravel the
pathophysiological mechanisms of FMD; to seek gene(s)
that predispose to the condition; to assess more accurately
the risk of disease progression in focal or multifocal FMD,Orphanet Journal of Rare Diseases 2007, 2:28 http://www.OJRD.com/content/2/1/28
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and in FMD affecting renal or extrarenal arteries; and to
improve the detection and quantification of renal artery
stenoses.
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